SCHEMBL13198230

SCHEMBL13198230

Cn1nc(-c2ccc3ccccc3c2)c2c(F)c(N)ccc21

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 14/20 0.55
PRKDC P78527 14/20 0.55
PIK3CA P42336 12/20 0.55
PIK3CB P42338 12/20 0.55
PIK3CG P48736 12/20 0.55
SRC P12931 8/20 0.55
ABL1 P00519 5/20 0.55
EGFR P00533 3/20 0.55
HCK P08631 3/20 0.55
KDR P35968 3/20 0.55
MTOR P42345 3/20 0.55
EPHB4 P54760 3/20 0.55
RIPK2 O43353 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
IKBKB O14920 1/20 0.38
TDP2 O95551 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13198235 0.82 PIK3CD (0.53) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL2869270 0.81 PIK3CD (0.44) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL13198226 0.76 SRC (0.49) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL13198227 0.76 PIK3CD (0.58) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL13198236 0.76 NPC1 (0.40) ADORA2A
SCHEMBL14074984 0.76 SRC (0.51) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL2863193 0.72 MAPKAPK2 (0.46) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL12551789 0.71 PIK3CD (1.00) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL14074983 0.70 SRC (0.45) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL13198228 0.70 SRC (0.48) PIK3CDPRKDCPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PIK3CD 2115/4885PRKDC 992/4885PIK3CA 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.